- Prison Planet.com - https://www.prisonplanet.com -

Pharma Backed Australian of the Year Psychiatrist Wants Millions in Government Funding for Brave New World of “Pre-Drugging” Kids

CCHR Int [1]
March 16, 2010

Who is Patrick McGorry and what does he promote?  He’s a psychiatrist just named Australian of the Year for his work in “youth mental health reform.”  What does that reform consist of?  What he calls a “new form of climate change.” It sure is.

[See TIME Magazine Article “Drugs Before Diagnosis?” [2]]

He not only promotes youths being put on antipsychotics and antidepressants, cited by international drug regulatory agencies as causing hallucinations, hostility, personality change, life-threatening diabetes, strokes, suicide and death, McGorry goes a giant step further—drug them before they’ve even developed a “psychiatric” disorder.

The Association for the Accreditation of Human Research Protection Programs (AHRPP) likens such concepts to “performing mastectomies on women who are at risk of—but do not have—breast cancer.”[i] [3]

The UN Committee on the Rights of the Child has expressed “serious concerns” about child drugging and Senate investigations in the United States have found high profile psychiatrists who were pharmaceutically funded and using fraudulent research being among the heaviest promoters of psychiatric drug use on children. While the rest of the world is experiencing serious alarm at the rampant use of deadly psychiatric drugs on children, McGorry pushes full steam ahead to increase the amount of children being needlessly subjected to psychiatry’s most powerful drugs—antidepressants and antipsychotics.

His theory and practices are so controversial that even his colleagues in the United States have backed away from it.  And a parallel study done in the United States based on the same theory that McGorry uses was considered an abject failure—even by the investigators themselves.  Other psychiatrists have criticized McGorry’s pre-drugging practice as unethical and harmful to adolescents.  More on that later.

This is especially so as the “symptoms” McGorry and cohorts invented to “pre-label” youths as potential candidates for psychosis and “schizophrenia” (to start with) are, according to one U.S. psychiatrist, “remarkably common…adolescence is a period of life that is normally marked by tumultuous changes in personality.”

And what was the first thing he did to capitalize on his winning his “Australian of the Year” award?  He demanded the Australian government hand over another $200 million to fund more of his centers where he can drug more children.  Worse, the government is entertaining the idea.

Yet, for who ever nominated him—apparently an “anonymous supporter”—due diligence wasn’t done on what McGorry advocates.

A cursory look at his research shows that while behavioral symptoms are evaluated and, on a hunch, drugged to see if they “prevent” the onset of a “mental” disorder, there’s no mention of the teens being given full and searching physical exams to first rule out undiagnosed and untreated medical conditions that may be causing it.  Yet dozens of physical conditions can manifest as behavioral problems.

A Closer Look at McGorry’s Brave New World

No Science to “Pre-Disorder” Screening

Harmful Drug Outcomes


Despite the Failure, Keep Lobbying for the $

Australia’s Joseph Biederman?

Australia’s health care system ranks well internationally, and preventative measures may seem the way to enhancing it; however, the last thing the country needs, then, is a psychiatrist banner heading the idea that children and youths should be gotten to early and drugged on the precept that they might become mentally ill.  Rather, they need proper medical—not psychiatric—care and educational solutions.  The last thing they need is $200 million of taxpayers’ dollars funding what could be a lifetime sentence to taking mind-altering drugs.

Someone needs to care for Australia’s children and youth, but it’s definitely not Patrick McGorry.

[i] [23] http://www.ministryoflies.com/pdf-articles/Yale-Lilly.pdf.


[ii] [24] http://www.bmj.com/cgi/content/full/337/aug04_1/a695.

[iii] [25] http://www.mhanet.ca/documents/2008/Research-Colloquium/0920%20-%20Keynote%20MCGORRY.pdf.

[iv] [26] http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2632176/.

[v] [27] http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2632176/.

[vi] [28] Arch Gen Psychiatry, Vol 59, Oct. 2002, http://www.meb.uni-bonn.de/psychiatrie/zebb/literatur/mcgorry.pdf.

[vii] [29] http://www.coreynahman.com/atypical-antipsychotic-lawsuits.html.

[viii] [30] http://www.ministryoflies.com/pdf-articles/Yale-Lilly.pdf.

[ix] [31] http://www.ministryoflies.com/pdf-articles/Yale-Lilly.pdf.

[x] [32] http://www.nytimes.com/2006/05/23/health/psychology/23prof.html?pagewanted=3&_r=1.

[xi] [33] http://www.time.com/time/magazine/article/0,9171,1205408,00.html#ixzz0i0DykBNV.

[xii] [34] http://www.time.com/time/magazine/article/0,9171,1205408,00.html#ixzz0i0NMJQyd.

[xiii] [35] http://www.camh.net/Publications/Cross_Currents/Winter_2007-08/futureorfad_crcuwinter0708.html.

[xiv] [36] Anthony Pelosi, “Head to Head, Is early intervention in the major psychiatric disorders justified? No,” BMJ 2008;337:a710, http://www.bmj.com/cgi/content/full/337/aug04_1/a710.

[xv] [37] http://www.camh.net/Publications/Cross_Currents/Winter_2007-08/futureorfad_crcuwinter0708.html.

[xvi] [38] http://www.bmj.com/cgi/content/full/337/aug04_1/a710.

[xvii] [39] http://www.ahrp.org/cms/index2.php?option=com_content&do_pdf=1&id=386; http://www.bioethicsforum.org/ethics-of-preventive-psychopharmacologic-treatments.asp.

[xviii] [40] http://www.ahrp.org/cms/index2.php?option=com_content&do_pdf=1&id=386; http://www.bioethicsforum.org/ethics-of-preventive-psychopharmacologic-treatments.asp.

[xix] [41] http://www.camh.net/Publications/Cross_Currents/Winter_2007-08/futureorfad_crcuwinter0708.html.

[xx] [42] http://www.bmj.com/cgi/content/full/337/aug04_1/a710.